Smart Money Alert

Biocon Limited

New PositionBlock Deal

BIOCONPharmaceuticalsMarket Cap₹60K Cr

Value

₹25.04 Cr

6,26,000

Price

₹400

Max Life Insurance

Institution

The move

Max Life Insurance bought 6,26,000 shares of Biocon for ₹25.04 Cr at ₹400.00 apiece in a block deal.

About Biocon Limited

Visit stock

A leading biotechnology company engaged in the manufacture of innovative pharmaceutical products and research services across multiple therapeutic areas. Biocon specializes in biologics, biosimilars, and small molecule drugs, serving patients in oncology, immunology, and diabetes therapeutics globally. The company operates integrated manufacturing facilities and maintains a strong commitment to developing affordable healthcare solutions for patients in emerging markets worldwide.

About Max Life Insurance

Visit investor

Now branded Axis Max Life after Axis Bank took a controlling stake. Crossed Rs 1.5 lakh crore in AUM in April 2024 with over 20% YoY growth and has continued to compound. CIO Sachin Bajaj has over 25 years of investment experience and runs a multi-cap equity book across ULIP, par and non-par funds with a quality and growth tilt.

Get the next move the moment it happens.

Follow Max Life Insurance and Biocon Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Biocon Limited shareholders Max Life Insurance's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Biocon Limited

Kotak Mutual FundIncreased

Kotak Mutual Fund bought 12,77,000 shares of Biocon Limited for ₹49.16 Cr at ₹385.00 apiece in a block deal.

9 Sept 2026

Government Pension Fund Global (Norway)New position

Government Pension Fund Global (Norway) bought 6,500,02 shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal on September 9, 2026.